Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

After IPO Success, Apogee Prepares To Take On Lilly And Sanofi Dupixent Across I&I

Nov 17 2023

• By Andrew McConaghie

Biotech

Related Content

Biotech IPOs Get Bigger, But Not Necessarily Better

Oct 04 2023

Sanofi Sees Dupixent As Just The Start Of COPD Transformation

Apr 27 2023

Merck Acquires Much Needed Diversification With $10.8bn Prometheus Buy

Apr 17 2023

Related Companies

Apogee Therapeutics, LLC

Merck & Co., Inc.

Sanofi

Eli Lilly and Company

Paragon Therapeutics, Inc.

Regeneron Pharmaceuticals, Inc.

Additional Topics

Commercial Companies StartUps and SMEs Inflammation Immune Disorders BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.